Brief: Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
15/05/2023 12:17
May 15 (Reuters) - Fulcrum Therapeutics Inc FULC.O :
* FULCRUM THERAPEUTICS APPOINTS ALEX C. SAPIR CHIEF
EXECUTIVE
OFFICER
* FULCRUM THERAPEUTICS - INTERIM CEO AND PRESIDENT, ROBERT
GOULD
WILL CONTINUE TO SERVE AS MEMBER OF BOARD OF DIRECTORS
FOLLOWING TRANSITION
Source text for Eikon: ID:nGNXDmmtB
Further company coverage: FULC.O
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program